The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Abstract
Steroids influence neuronal function through binding to cognate intracellular receptors which may act as transcription factors in the regulation of gene expression. In addition, certain so-called neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially distinct 3alpha-reduced metabolites of progesterone and deoxycorticosterone are potent positive allosteric modulators of gamma-aminobutyric acid type A (GABA(A)) receptors. However, also classical steroid hormones such as 17beta-estradiol, testosterone and progesterone are neuroactive steroids because they may act as functional antagonists at the 5-hydroxytryptamine type 3 (5-HT(3)) receptor, a ligand-gated ion channel or distinct glutamate receptors. A structure-activity relationship for the actions of a variety of steroids at the 5-HT(3) receptor was elaborated that differed considerably from that known for GABA(A) receptors. Although a bindings site for steroids at GABA(A) receptors is still a matter of debate, meanwhile there is also evidence that steroids interact allosterically with ligand-gated ion channels at the receptor membrane interface. On the other hand, also 3alpha-reduced neuroactive steroids may regulate gene expression via the progesterone receptor after intracellular oxidation into 5alpha-pregnane steroids. Animal studies showed that progesterone is converted rapidly into GABAergic neuroactive steroids in vivo. Progesterone reduces locomotor activity in a dose-dependent fashion in male Wistar rats. Moreover, progesterone and 3alpha-reduced neuroactive steroids produce a benzodiazepine-like sleep EEG profile in rats and humans. During major depression, there is a disequilibrium of such 3alpha-reduced neuroactive steroids which is corrected by successful treatment with antidepressant drugs. Neuroactive steroids may further be involved in the treatment of depression and anxiety with antidepressants in patients during ethanol withdrawal. Studies in patients with panic disorder suggest that neuroactive steroids may also play a role in modulating human anxiety. Both the genomic and non-genomic effects of steroids in the brain may contribute to the pathophysiology of psychiatric disorders and the mechanisms of action of antidepressants. Neuroactive steroids affect a broad spectrum of behavioral functions through their unique molecular properties and may represent a new treatment strategy for neuropsychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Huppert, F., & Van Niekerk, J. (2001) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000304 · Cited by 88
RetractedThe Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,534
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,413
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R., & Julius, D. J. (1991) · Science · doi:10.1126/science.1718042 · Cited by 978
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B. J., Jones, S. A., Wisely, G. B., Serabjit‐Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 946
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
Truss, M., & Beato, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 739
Research works printed but not linked: 3
- Carter, 1997, Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3-methyl-5α-pregnan-20-one), a selective high-affinity steroid modulator of the GABAA receptor, J. Pharmacol. Exp. Ther., 280, 1284
- Monteleone, 2000, Allopregnanlone concentrations and premenstrual syndrome, Eur, J. Endocrinol., 142, 269
- Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Hermann, B., Gajewski, G., Holsboer, F., Rupprecht, R. Induced panic attacks shift GABAA receptor modulatory steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry, in press.
Cited by
Sorted by citations
Items 101–200 of 428
Alterations in DHEA metabolism in schizophrenia: Two-month case-control study
Ritsner, M. S., Gibel, A., Ram, E., Maayan, R., & Weizman, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.07.007 · Cited by 60
Bansal, R., & Singh, R. (2017) · Medicinal Research Reviews · doi:10.1002/med.21458 · Cited by 62
Chávez-Castillo, M., Núñez, V., Nava, M., Ortega, Á., Rojas, M., Bermúdez, V., & Rojas, J. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/7943481 · Cited by 60
Neurosteroids as neuromodulators in the treatment of anxiety disorders
Longone, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00055 · Cited by 59
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Nothdurfter, C., Baghai, T. C., Schüle, C., & Rupprecht, R. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0352-5 · Cited by 60
Self-citationTargeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Fox, H., Hong, K., Paliwal, P., Morgan, P. T., & Sinha, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0936-3 · Cited by 56
Barrantes, F. J. (2003) · PubMed · Cited by 55
Neuroactive steroids as modulators of depression and anxiety
Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.007 · Cited by 54
Self-citationSalivary Testosterone Levels in Men at a U.S. Sex Club
Escasa-Dorne, M. J., Casey, J. F., & Gray, P. B. (2010) · Archives of Sexual Behavior · doi:10.1007/s10508-010-9711-3 · Cited by 53
Progesterone attenuates cocaine-induced responses
Quiñones-Jenab, V., & Jenab, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.10.002 · Cited by 54
Cutler, S. M., VanLandingham, J. W., Murphy, A. Z., & Stein, D. G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.029 · Cited by 53
Ferando, I., & Mody, I. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00144 · Cited by 52
Pharmacology of serotonin and female sexual behavior
Uphouse, L. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.008 · Cited by 52
Milman, A., Zohar, O., Maayan, R., Weizman, R., & Pick, C. G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.007 · Cited by 52
The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia
Ritsner, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.017 · Cited by 51
Tapered progesterone withdrawal promotes long-term recovery following brain trauma
Cutler, S. M., VanLandingham, J. W., & Stein, D. G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.137 · Cited by 52
Teubel, J., Wuest, B., Schipke, C. G., Peters, O., & Parr, M. K. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.04.035 · Cited by 51
Allopregnanolone and reproductive psychiatry: an overview
McEvoy, K., & Osborne, L. M. (2019) · International Review of Psychiatry · doi:10.1080/09540261.2018.1553775 · Cited by 51
Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone
Pinna, G. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00114 · Cited by 52
Stuursma, A., Lanjouw, L., Idema, D. L., de Bock, G. H., & Mourits, M. J. E. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.08.191 · Cited by 52
Anxiolytic effect of music depends on ovarian steroid in female mice
Chikahisa, S., Sano, A., Kitaoka, K., Miyamoto, K., & Séi, H. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.010 · Cited by 49
Hormonal therapy and depression: Are we overlooking an important therapeutic alternative?
Ancelin, M., Scali, J., & Ritchie, K. A. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.12.019 · Cited by 50
Neuroactive Steroids in Depression and Anxiety Disorders: Clinical Studies
Eser, D., Schüle, C., Baghai, T. C., Romeo, E., & Rupprecht, R. (2006) · Neuroendocrinology · doi:10.1159/000097879 · Cited by 49
Self-citationRodríguez‐Landa, J. F., Contreras, C. M., & García-Ríos, R. I. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328331b9f2 · Cited by 48
Androgens modulate chronic intermittent hypoxia effects on brain and behavior
Snyder, B., Duong, P., Trieu, J., & Cunningham, R. L. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.09.005 · Cited by 48
Rasmusson, A. M., Picciotto, M. R., & Krishnan‐Sarin, S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060193 · Cited by 49
Amygdala protein kinase C epsilon regulates corticotropin‐releasing factor and anxiety‐like behavior
Lesscher, H. M. B., McMahon, T., Lasek, A. W., Chou, W.-H., Connolly, J., Kharazia, V., & Messing, R. O. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00356.x · Cited by 47
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview
Vismara, M. E. M., Girone, N., Cirnigliaro, G., Fasciana, F., Vanzetto, S., Ferrara, L., Priori, A., D’Addario, C., Viganò, C. A., & Dell’Osso, B. M. (2020) · Brain Sciences · doi:10.3390/brainsci10080564 · Cited by 48
van der Ven, K., Keil, D., Moens, L., van Leemput, K., van Remortel, P., & Coen, W. M. D. (2006) · Environmental Toxicology and Chemistry · doi:10.1897/05-495r.1 · Cited by 47
Mòdol, L., Darbra, S., & Pallarès, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.058 · Cited by 46
Kumari, V., Konstantinou, J., Papadopoulos, A. S., Aasen, I., Poon, L., Halari, R., & Cleare, A. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.195 · Cited by 46
The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function
Vinson, G. P. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0178 · Cited by 46
Reis, F., Pestana‐Oliveira, N., Leite, C. M., Lima, F. B., Brandão, M. L., Graeff, F. G., Del‐Ben, C. M., & Anselmo-Franci, J. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.019 · Cited by 46
Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides
Мокров, Г. В., Деева, О. А., Гудашева, Т. А., Ярков, С. А., Яркова, М. А., & Середенин, С. Б. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.049 · Cited by 45
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?
Ebinger, M., Sievers, C., Ivan, D., Schneider, H., & Stalla, G. K. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092337 · Cited by 47
Maingat, F. G., Polyak, M. J., Paul, A. M., Vivithanaporn, P., Noorbakhsh, F., Ahboucha, S., Baker, G. B., Pearson, K. G., & Power, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-215079 · Cited by 45
Eser, D., di Michele, F., Zwanzger, P., Pasini, A., Baghai, T. C., Schüle, C., Rupprecht, R., & Romeo, E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300572 · Cited by 45
Self-citationSato, T. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.006 · Cited by 45
Baghai, T. C., di Michele, F., Schüle, C., Eser, D., Zwanzger, P., Pasini, A., Romeo, E., & Rupprecht, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300684 · Cited by 45
Self-citationLazzer, S., Lafortuna, C. L., Busti, C., Galli, R., Agosti, F., & Sartório, A. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346694 · Cited by 44
Rupprecht, R., Pradhan, A. K., Kufner, M., Brunner, L.-M., Nothdurfter, C., Wein, S., Schwarzbach, J. V., Puig-Bosch, X., Rupprecht, C., & Rammes, G. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01532-3 · Cited by 45
Self-citationRegulation of Neurosteroid Biosynthesis by Neurotransmitters and Neuropeptides
do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Vaudry, D., Luu-The, V., Tonon, M., Tsutsui, K., Pelletier, G., & Vaudry, H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00004 · Cited by 45
Neurosteroids: Endogenous Modulators of Seizure Susceptibility
Rogawski, M. A., & Reddy, D. S. (2004) · Cited by 43
Chuang, S.-H., & Reddy, D. S. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261735 · Cited by 42
Sex Differences and Hormonal Influences in Human Sensorimotor Gating: Implications for Schizophrenia
Kumari, V. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_117 · Cited by 42
Yıldırım, O., Doğan, O., Semız, M., & Kılıçlı, F. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02252.x · Cited by 41
Barron, A. M., Higuchi, M., Hattori, S., Kito, S., Suhara, T., & Ji, B. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02136-5 · Cited by 44
CYP2C19 polymorphism affects personality traits of Japanese females
Ishii, G., Suzuki, A., Oshino, S., Shiraishi, H., & Otani, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.012 · Cited by 41
Costa, B., Pozzo, E. D., Chelli, B., Simola, N., Morelli, M., Luisi, M., Maccheroni, M., Taliani, S., Simorini, F., Settimo, F. D., et al. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.021 · Cited by 41
Steroid Sulfation in Neurodegenerative Diseases
Vítků, J., Hill, M., Kolátorová, L., Havrdová, E., & Kancheva, R. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839887 · Cited by 42
Frye, C. A., Paris, J. J., Walf, A. A., & Rusconi, J. C. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00136 · Cited by 40
Cocaine, Hormones, and Behavior: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00098-x · Cited by 39
Neuroendocrine Regulation of Sleep Disturbances in PTSD
Neylan, T. C., Otte, C., Yehuda, R., & Marmar, C. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.015 · Cited by 39
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders
Eser, D., Schüle, C., Romeo, E., Baghai, T. C., di Michele, F., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0188-z · Cited by 39
Self-citationGuerra‐Araiza, C., Amorim, M. A. R., Pinto‐Almazán, R., González‐Arenas, A., Campos, M. G., & García‐Segura, L. M. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21848 · Cited by 37
Tomaselli, G., & Vallée, M. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100789 · Cited by 41
Mello, N. K., Knudson, I. M., Kelly, M., Fivel, P. A., & Mendelson, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.130 · Cited by 37
Patisaul, H. B., Blum, A., Luskin, J. R., & Wilson, M. E. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.2.587 · Cited by 35
Progestin Receptor-Mediated Reduction of Anxiety-Like Behavior in Male Rats
Auger, C. J., & Forbes‐Lorman, R. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003606 · Cited by 35
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
McEvoy, K., Payne, J. L., & Osborne, L. M. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0937-4 · Cited by 35
Sankar, J. S., & Hampson, E. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.05.001 · Cited by 35
Monteleone, P., Santonastaso, P., Pannuto, M., Favaro, A., Caregaro, L., Castaldo, E., Zanetti, T., & Maj, M. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.019 · Cited by 35
Petralia, S. M., Jahagirdar, V., & Frye, C. A. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01342.x · Cited by 35
Individual variability, end-point effects and possible biases in electrophysiological research
Sannita, W. G. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.04.026 · Cited by 35
Strain-Dependent Changes in Acoustic Startle Response and its Plasticity Across Adolescence in Mice
Pietropaolo, S., & Crusio, W. E. (2009) · Behavior Genetics · doi:10.1007/s10519-009-9291-y · Cited by 34
Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids
Jäntti, S. E., Kiriazis, A., Reinilä, R., Kostiainen, R. K., & Ketola, R. A. (2007) · Steroids · doi:10.1016/j.steroids.2006.11.023 · Cited by 34
Gender and Neurosteroids: Implications for Brain Function, Neuroplasticity and Rehabilitation
Raciti, L., Formica, C., Raciti, G., Quartarone, A., & Calabrò, R. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054758 · Cited by 33
Balan, I. S., Boero, G., Chéry, S. L., McFarland, M. H., Lopez, A. G., & Morrow, A. L. (2024) · Life · doi:10.3390/life14050582 · Cited by 36
Dias, R. D. S., Kerr-Corrêa, F., Moreno, R. A., Trinca, L. A., Pontes, A., Halbe, H. W., Gianfaldoni, A., & Dalben, I. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000198491.34371.9c · Cited by 33
Pinto‐Almazán, R., Calzada‐Mendoza, C. C., Campos-Lara, M. G., & Guerra‐Araiza, C. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22808 · Cited by 35
Giatti, S., Diviccaro, S., Falvo, E., García‐Segura, L. M., & Melcangi, R. C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100836 · Cited by 33
The burden of depression in systemic sclerosis patients: a nationwide population-based study
Bragazzi, N. L., Watad, ., Gizunterman, A., McGonagle, D., Mahagna, H., Comaneshter, D. S., Amital, H., Cohen, A. D., & Amital, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.075 · Cited by 32
Deligiannidis, K. M., Kroll-Desrosiers, A. R., Tan, Y., Dubuke, M. L., & Shaffer, S. A. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104827 · Cited by 31
Kaufman, Y., Carlini, S. V., & Deligiannidis, K. M. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211065859 · Cited by 30
Venâncio, D. P., Tufik, S., Garbuio, S. A., da Nóbrega, A. C. L., & de Mello, M. T. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0621-6 · Cited by 30
Myelin Disorders: Causes and Perspectives of Charcot-Marie-Tooth Neuropathy
zu Hörste, G. M., Prukop, T., Nave, K., & Sereda, M. W. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:77 · Cited by 30
Morota, S., Månsson, R., Hansson, M. J., Kasuya, K., Shimazu, M., Hasegawa, E., Yanagi, S., Omi, A., Uchino, H., & Elmér, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.036 · Cited by 31
Niemann Pick Type C Disease as a Model for Defects in Neurosteroidogenesis
Mellon, S. H., Gong, W., & Griffin, L. D. (2004) · Endocrine Research · doi:10.1081/erc-200044016 · Cited by 30
Progesterone and its metabolites as therapeutic targets in psychiatric disorders
Bristot, G., Ascoli, B. M., Gubert, C., Panizzutti, B., Kapczinski, F. P., & Rosa, A. R. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.897329 · Cited by 32
Gut feelings: the microbiota-gut-brain axis on steroids
So, S. Y., & Savidge, T. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00294.2021 · Cited by 29
Milivojevic, V., Sullivan, L., Tiber, J., Fogelman, N., Simpson, C. A., Hermes, G., & Sinha, R. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06278-3 · Cited by 30
Allopregnanolone produces hyperphagia by reducing neophobia without altering food palatability
Fudge, M. A., Kavaliers, M., & Ossenkopp, K. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.08.002 · Cited by 29
Role of 5-HT1A receptors in fluoxetine-induced lordosis inhibition
Guptarak, J., Sarkar, J., Hiegel, C., & Uphouse, L. L. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.03.003 · Cited by 28
Schüle, C., Baghai, T. C., Eser, D., Schwarz, M., Bondy, B., & Rupprecht, R. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.07.003 · Cited by 28
Self-citationEspallergues, J., Mamiya, T., Vallée, M., Koseki, T., Nabeshima, T., Temsamani, J., Laruelle, C., & Maurice, T. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.005 · Cited by 30
Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System
Schumacher, M., Zhu, X., & Guennoun, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00054-7 · Cited by 30
Beerda, B., Wyszyńska-Koko, J., PAS, M. F. W. T., de Wit, A. A. C., & Veerkamp, R. F. (2008) · animal · doi:10.1017/s1751731108002371 · Cited by 27
The 3β-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice
Espallergues, J., Givalois, L., Temsamani, J., Laruelle, C., & Maurice, T. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.11.003 · Cited by 26
SCHÜSSLER, P., Kluge, M., Adamczyk, M., Beitinger, M. E., Beitinger, P. A., Bleifuss, A., Cordeiro, S., Mattern, C., Uhr, M., Wetter, T. C., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.001 · Cited by 26
Self-citationFeng, X., Dong, Y. W., Fu, Y., Zhu, Y., Sun, J., Wang, Z., Sun, F., & Zheng, P. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.002 · Cited by 29
Effect of an Oral Contraceptive with Chlormadinone Acetate on Depressive Mood
Huber, J. C., Heskamp, M. ‐. S., & Schramm, G. A. K. (2008) · Clinical Drug Investigation · doi:10.2165/0044011-200828120-00006 · Cited by 25
GABAAreceptors as targets for novel anxiolytic drugs
Rupprecht, R., Eser, D., Zwanzger, P., & Möller, H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600868525 · Cited by 25
Self-citationPrecision medicine in perinatal depression in light of the human microbiome
Bernabé, B. P., Maki, P. M., Dowty, S. M., Salas, M. L. C., Cralle, L. E., Shah, Z., & Gilbert, J. A. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05436-4 · Cited by 26
Zwanzger, P., Eser, D., Padberg, F., Baghai, T. C., Schüle, C., Rupprecht, R., di Michele, F., Romeo, E., Pasini, A., & Ströhle, A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00109-2 · Cited by 25
Self-citationWolkowitz, O. M., & Reus, V. I. (2003) · The World Journal of Biological Psychiatry · doi:10.1080/15622970310029901 · Cited by 25
Rupprecht, R., Rupprecht, C., Benedetto, B. D., & Rammes, G. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1961503 · Cited by 24
Self-citationGao, X., Sun, P., Qiao, M., Wei, S., Xue, L., & Zhang, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2599 · Cited by 24
Silva, A. F., Sousa, D. S., Medeiros, A. M., Macêdo, P. T., Leão, A. H. F. F., Ribeiro, A. M., Izídio, G. S., & Silva, R. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.05.003 · Cited by 25
Reddy, A. P., & Bethea, C. L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2154-1 · Cited by 24
Metadata
- Authors
- Rupprecht, R.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Rupprecht, R.
- ORCID
- Rupprecht, R.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 28
- Issue
- 2
- Pages
- 139-168
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2047844288
- Cited by
- 427
- References
- 151
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 14 · 2022: 13 · 2021: 6 · 2020: 11 · 2019: 14 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 18 · 2014: 14 · 2013: 18 · 2012: 26
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- neurosteroids, progesterone, deoxycorticosterone, GABA-A receptor modulation, 5-HT3 receptor antagonism, glutamate receptors, non-genomic steroid action, steroid hormone receptors, locomotor activity, sleep EEG, depression, anxiety, ethanol withdrawal, panic disorder, antidepressants, mental illness
- MeSH terms
- Anesthesia, Animals, Anticonvulsants, Antidepressive Agents, Humans, Nervous System, Receptors, GABA-A, Receptors, Serotonin, Sleep, Steroids, Antipsychotic Agents, Anti-Anxiety Agents, Gene Expression, Receptors, Neurotransmitter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review